About Firm News
In the News
Lisa Dwyer discusses the FTC’s use of the FDA’s process for disputing listings in its Orange Book
November 28, 2023
| Pink Sheet Citeline Regulatory

Go to the article

Related Capabilities
Special Matters & Government Investigations FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
Special Matters & Government Investigations
Learn More
a blue and green background
Capabilities
FDA & Life Sciences
Learn More